LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Sean McCarthy will join a roundtable discussion of "How to Transform your Technology into a Sustainable Marketable Product" at the San Jose BioCenter.
News | 03. 22. 2007
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.